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Abstract The ability of low concentrations (5^15 WM) of long-
chain fatty acids to open the permeability transition pore (PTP)
in Ca2+-loaded mitochondria has been ascribed to their
protonophoric effect mediated by mitochondrial anion carriers,
as well as to a direct interaction with the pore assembly [M.R.
Wieckowski and L. Wojtczak, FEBS Lett. 423 (1998) 339^342].
Here, we have compared the PTP opening ability of arachidonic
acid (AA) with that of carbonyl cyanide-p-trifluoromethoxyphe-
nylhydrazone (FCCP) at concentrations that cause similar
quantitative dissipation of the membrane potential (v8) in
Ca2-loaded rat liver mitochondria respiring on succinate. The
initial protonophoric effects of AA and FCCP were only slightly
modified by carboxyatractyloside and were followed by PTP
opening, as indicated by a second phase of v8 disruption
sensitive to EGTA, ADP, dithiothreitol and cyclosporin A. This
second phase of v8 dissipation could also be prevented by
rotenone or NAD(P)H-linked substrates which decrease the
pyridine nucleotide (PN) oxidation that follows the stimulation
of oxygen consumption induced by AA or FCCP. These results
suggest that, under the experimental conditions used here, the
PTP opening induced by AA or FCCP was a consequence of PN
oxidation. Exogenous catalase also inhibited both AA- and
FCCP-induced PTP opening. These results indicate that a
condition of oxidative stress associated with the oxidized state of
PN underlies membrane protein thiol oxidation and PTP
opening.
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1. Introduction
Although the ability of non-esteri¢ed long-chain fatty acids
(FA) to uncouple oxidative phosphorylation has been known
for a long time [1], only recently was this mechanism clari¢ed
by the concept of the fatty acid cycle put forward by Skula-
chev [2]. According to this model, which has been con¢rmed
by several independent lines of evidence (for reviews, see
[3,4]), protonated FA movement to the mitochondrial matrix
is passively driven by the vpH across the phospholipid bilayer
of the inner membrane (£ip-£op mechanism). The deproto-
nated FA anion is subsequently exported electrophoretically
by mitochondrial anion carriers such as the ATP/ADP anti-
porter (ANT) [2], the aspartate/glutamate antiporter [5], the
dicarboxylate carrier [6] or uncoupling proteins [2,3]. In each
round of the FA cycle, one proton is left behind in the matrix.
In addition to their ability to speci¢cally uncouple oxidative
phosphorylation, FA are also able to open the permeability
transition pore (PTP) [7,8] in Ca2-loaded mitochondria.
Since opening of the PTP is facilitated at lower transmem-
brane potentials (v8) [9^11], the ability of FA, at low con-
centrations, to open the PTP has been ascribed to their pro-
tonophoric action and to their direct interaction with the
ANT [7], a putative component of the pore assembly
[11,12]. Another characteristic of the PTP is its ability to
open under conditions of oxidative stress (for review, see
[13]), a condition that may oxidize thiol groups in the ANT
[11,14]. Vercesi [9] proposed a link between the mitochondrial
membrane potential and PTP opening through the energy-
linked NAD(P)H transhydrogenase which uses the v8 to dis-
place the redox potential of NADP to a more reduced state
[15]. This coenzyme is the source of mitochondrial reducing
equivalents that allows glutathione reductase/glutathione per-
oxidase to scavenge most of the reactive oxygen species (ROS)
produced by mitochondria [16], thus protecting the organelle
against PTP opening [14] and lipid peroxidation [17]. At low
membrane potential, this antioxidant process is impaired and
a condition of oxidative stress may arise [16]. In addition,
earlier data [18] provided evidence that ANT thiols may be
oxidized when the level of NAD(P)H is low, a condition that
favors PTP opening [18].
Since both FA and the classical protonophore carbonyl
cyanide-p-tri£uoromethoxyphenylhydrazone (FCCP) stimu-
late oxygen consumption and shift the electron transfer com-
ponents of the respiratory chain to a more oxidized state, we
have examined the possible participation of the NAD(P) re-
dox state in the mechanism of FA- and FCCP-induced PTP
opening. Given the possible participation of the PTP in both
necrotic and apoptotic cell death [12] and the fact that arach-
idonic acid (AA) may participate as a secondary messenger in
both modes of cell death [19], we have used this FA to assess
the mechanism of PTP opening.
2. Materials and methods
2.1. Isolation of rat liver mitochondria and standard incubation
procedure
Rat liver mitochondria (RLM) were isolated by conventional di¡er-
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ential centrifugation from the livers of adult female Wistar rats fasted
overnight. The experiments were carried out at 30‡C in a standard
medium containing 125 mM sucrose, 65 mM KCl, 10 mM HEPES
(2-hydroxyethyl-1-piperazineethanesulfonic acid), pH 7.2, 2 mM
KH2PO4, 1 mM MgCl2 and 5 mM succinate. The experiments were
done in glass cuvettes with magnetic stirring in a ¢nal volume of 2.0
ml and a protein concentration of 0.5 mg ml31. Other additions are
indicated in the ¢gure legends. The results shown are representative or
averages of at least three experiments.
2.2. Measurements of mitochondrial transmembrane electrical potential
(v8)
The mitochondrial membrane potential (v8) was estimated by
measuring the £uorescence changes of safranin O (5 WM) [20], using
a model F-4010 Hitachi spectro£uorometer (Hitachi, Ltd., Tokyo,
Japan) operated at excitation and emission wavelengths of 495 nm
and 586 nm, respectively, and a slit width of 5 nm. A calibration curve
was obtained when mitochondria were incubated in K-free reaction
medium containing 250 mM sucrose, 10 mM Na^HEPES bu¡er (pH
7.2) and 0.5 mM EGTA. The changes in the £uorescence of safranin
induced by mitochondrial energization were similar in the absence or
presence of K. In all experiments, one £uorescence unit corre-
sponded to 40 mV.
2.3. Determination of Ca2+ movement
Variations in the concentration of free Ca2 were followed by meas-
uring the changes in the absorbance spectrum of arsenazo III [21],
using an SLM Aminco DW2000 spectrophotometer set at the wave-
length pair 675^685 nm.
2.4. Determination of the NAD(P) redox state
The oxidation or reduction of pyridine nucleotides in the mitochon-
drial suspension was followed in a Hitachi F-4010 spectro£uorometer
(Hitachi, Ltd., Tokyo, Japan) operating at excitation and emission
wavelengths of 366 and 450 nm, respectively, with a slit width of
5 nm.
2.5. Oxygen uptake measurements
Oxygen consumption was measured using a Clark-type electrode
(Yellow Springs Instruments, OH, USA) in 1.3 ml of standard reac-
tion medium (30‡C), in a sealed glass cuvette equipped with a mag-
netic stirrer.
2.6. Materials
Safranin O, catalase (C10), cyclosporin A (CsA), HEPES, arsenazo
III, rotenone, EGTA, antimycin A, ADP, K-nicotinamide adenine
dinucleotide (reduced form, K-NADH), FCCP, dithiothreitol (DTT),
succinate, L-hydroxybutyrate, isocitrate and carboxyatractyloside
were from Sigma Chemical Company (St. Louis, MO, USA). All
other reagents were of the highest grade available.
3. Results
3.1. Membrane potential alterations induced by AA and FCCP
in Ca2+-loaded rat liver mitochondria
Fig. 1 shows that when RLM were added to the standard
medium containing 30 WM free Ca2 and 5 mM succinate as
substrate, there was a fast decrease in the £uorescence of
safranin compatible with the formation of a membrane poten-
tial. The addition of 10 WM AA (panel A, line a) or 50 nM
FCCP (panel B, line a) caused a biphasic decrease in the
membrane potential (v8). The ¢rst phase (about 20 mV)
was compatible with a pure protonophoric e¡ect of these
compounds and was followed by a larger second phase of
membrane depolarization compatible with the mitochondrial
permeability transition (MPT). The initial protonophoric ef-
fect was partially inhibited, whereas the second phase of the
decrease in v8 was totally prevented by the permeability tran-
sition inhibitors ADP (lines c), catalase (lines d), DTT (lines
e), EGTA (lines f) and CsA (lines g). Rotenone (lines h) and
the NAD(P)H-linked substrates L-hydroxybutyrate plus isoci-
trate (lines i) had similar e¡ects. Carboxyatractyloside (1.0
WM, lines b) caused only a very small inhibition at pH 7.2,
in agreement with a previous report [5]. Lines j represent
control experiments without AA or FCCP. The addition of
antimycin A at the end of the experiments caused a total
collapse of v8.
3.2. Stimulation of respiration and mitochondrial NAD(P)H
oxidation induced by AA and FCCP
Mitochondrial pyridine nucleotides are a source of reducing
equivalents for the antioxidant enzyme system glutathione re-
ductase/glutathione peroxidase, which converts H2O2 into
H2O, thereby preventing the formation of hydroxyl radicals
(HO) that attack protein thiols leading to MPT [18]. Fig. 2
compares the changes in NAD(P)H £uorescence when the rate
of respiration is stimulated by AA or FCCP in mitochondria
oxidizing succinate in the absence of rotenone (Fig. 3). The
£uorescence measurements were done in the presence of 1.0
WM CsA to prevent any changes in light scattering caused by
the mitochondrial swelling that follows NAD(P)H oxidation
in Ca2-loaded mitochondria [18]. The addition of 10 WM AA
(panel A, line a) or 50 nM FCCP (panel B, line a) caused a
large, fast decrease in £uorescence, compatible with the oxi-
dation of almost 100% of the mitochondrial NAD(P)H [9].
When RLM were incubated with 4 WM rotenone (lines h) or
5 mM L-hydroxybutyrate and 0.1 mM isocitrate (lines g), the
addition of AA or FCCP caused much less NAD(P)H oxida-
tion. Only very low inhibition of NAD(P)H oxidation oc-
curred in the presence of 1.0 WM carboxyatractyloside (lines
b), 200 nmol ADP (lines c), 2.0 WM catalase (lines d), 2 mM
DTT (lines e) or 1 mM EGTA (lines f). Lines i represent
control experiments without AA or FCCP. The rate of respi-
ration (Fig. 3) was slightly faster in the presence of FCCP
(151.96 þ 1.45 nmol O2 min31 mg protein31) than in the pres-
ence of AA (128.18 þ 2.65 nmol O2 min31 mg protein31). The
rate of state 4 respiration in the control experiments (line a)
was 22.94 þ 0.35 nmol O2 min31 mg protein31.
Fig. 1. Mitochondrial membrane potential collapse induced by AA
and FCCP: the e¡ects of ADP, catalase, carboxyatractyloside,
DTT, EGTA, CsA and rotenone. RLM (0.5 mg ml31) were incu-
bated in medium containing 125 mM sucrose, 65 mM KCl, 10 mM
HEPES, pH 7.2, 2 mM KH2PO4, 1 mM MgCl2, 5 mM sodium suc-
cinate, 30 WM CaCl2 and 5 WM safranin, at 30‡C. As indicated, 10
WM AA (panel A, line a) or 50 nM FCCP (panel B, line a) was
added in the presence of 1 WM carboxyatractyloside (lines b), 200
nmol ADP and 2 Wg oligomycin ml31 (lines c), 2.0 WM catalase
(lines d), 2 mM DTT (lines e), 1 mM EGTA (lines f), 1.0 WM CsA
(lines g), 4 WM rotenone (lines h) or 5 mM L-hydroxybutyrate plus
0.1 mM isocitrate (lines i). Lines j represent control experiments
without additions. Antimycin A (1 Wg ml31) was added at the end
of the experiments.
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3.3. Re-reduction of NAD(P)+ by rotenone and
NAD(P)H-linked substrates prevents PTP opening by
AA or FCCP
Although very little is known about the structure and bio-
logical role of the PTP, the mechanisms of inhibition of the
membrane permeability transition by ADP, DTT, catalase
and CsA have been described and are related to direct or
indirect interactions with the ANT (by ADP or CsA, respec-
tively) or the antioxidant action of catalase and DTT. The
following experiments were designed to ascertain whether re-
reduction of NAD(P) by rotenone or NAD(P)H-linked sub-
strates correlated with their inhibitory e¡ect against opening
of the PTP. The combination of L-hydroxybutyrate and iso-
citrate promptly re-reduces NAD(P) and reverses Ca2 re-
lease from rat liver mitochondria treated with prooxidants
[9,22]. Fig. 4 shows that L-hydroxybutyrate plus isocitrate
(lines b), rotenone (lines c), or rotenone plus L-hydroxybuty-
rate and isocitrate (lines d), added after AA or FCCP (lines
a), caused signi¢cant re-reduction of NAD(P). As expected,
rotenone caused an almost complete reduction of NAD(P).
This was faster when NAD(P)-linked substrates were added
together. To assess whether the second phase of the v8 dis-
ruption was the consequence of NAD(P)H oxidation, the
changes in v8 when these NAD(P) reductants were added
after the ¢rst phase of the v8 decrease induced by AA or
FCCP (lines a) were monitored. Fig. 5 shows that NAD(P)
re-reduction did indeed prevent the second phase of the v8
decrease. When the re-reduction was more complete by the
simultaneous addition of rotenone and NAD(P)-linked sub-
strates, the v8 returned almost to the level of the control
experiment in panel A, line d. Lines e represent control experi-
ments without AA or FCCP. The addition of antimycin A
caused the collapse of v8.
3.4. Characteristics of mitochondrial Ca2+ release induced by
AA or FCCP
Fig. 6 shows that when RLM were added to a standard
reaction medium containing 5 mM succinate and 30 WM
CaCl2, most of the Ca2 present was quickly taken up by
mitochondria (lines e). The addition of 10 WM AA (panel
A, line a) or 50 nM FCCP (panel B, line a) was followed
by the release of accumulated and endogenous Ca2 into
the medium. The mitochondrial Ca2 release induced by AA
or FCCP was totally inhibited by rotenone (lines b), L-hy-
droxybutyrate plus isocitrate (lines c) or all of these together
(lines d). Similar e¡ects were obtained with ADP with or
without oligomycin, DTT, CsA, catalase, but not with car-
Fig. 2. Mitochondrial NAD(P)H oxidation induced by AA or
FCCP. RLM (0.5 mg ml31) were incubated at 30‡C in standard re-
action medium containing 1 WM CsA to prevent changes in light
scattering due to mitochondrial swelling caused by Ca2. Panel A,
line a, shows the addition of 10 WM AA, and panel B, line a, that
of 50 nM FCCP. Other additions were: 1.0 WM carboxyatractylo-
side (lines b), 200 nmol ADP and 2 Wg oligomycin ml31 (lines c),
2.0 WM catalase (lines d), 2 mM DTT (lines e), 1 mM EGTA (lines
f), 5 mM L-hydroxybutyrate and 0.1 mM isocitrate (lines g) and
4 WM rotenone (lines h). Lines i represent control experiments, with-
out additions.
Fig. 3. Release of state 4 respiration by AA or FCCP. RLM (0.5 mg
ml31) were incubated in standard reaction medium at 30‡C. Line b
shows the addition of 10 WM AA and line c, that of 50 nM FCCP.
Line a represents control experiment without additions.
Fig. 4. NAD(P) reduction induced by rotenone and NAD(P)H-
linked substrates. RLM (0.5 mg ml31) were incubated in standard
reaction medium at 30‡C. Panel A, line a, shows the addition of
10 WM AA, and panel B, line a, that of 50 nM FCCP. Where indi-
cated by the arrow, the following were added: 5 mM L-hydroxybu-
tyrate and 0.1 mM isocitrate (lines b), 4 WM rotenone (lines c) and
4 WM rotenone, 5 mM L-hydroxybutyrate and 0.1 mM isocitrate
(lines d). Lines e represent control experiments without additions.
Fig. 5. Rotenone or NAD(P)H-linked substrates added after the ini-
tial protonophoric e¡ect of AA or FCCP prevent v8 disruption in
Ca2-loaded RLM. RLM (0.5 mg ml31) were incubated at 30‡C in
medium containing 125 mM sucrose, 65 mM KCl, 10 mM HEPES,
pH 7.2, 2 mM KH2PO4, 1 mM MgCl2, 5 mM sodium succinate,
30 WM CaCl2 and 5 WM safranin. In all experiments, 10 WM AA
(panel A, line a) or 50 nM FCCP (panel B, line a) was added.
Where indicated by the arrow, the following were added: 5 mM
L-hydroxybutyrate and 0.1 mM isocitrate (lines b), 4 WM rotenone
(lines c) and 4 WM rotenone, 5 mM L-hydroxybutyrate and 0.1 mM
isocitrate (lines d). Lines e represent control experiments.
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boxyatractyloside (not shown). The amount of Ca2 released
by antimycin A was the same in all the experimental condi-
tions used (not shown). This eliminated the possibility that
isocitrate could be protecting against PTP by chelating an
appreciable amount of the cation.
4. Discussion
It is now widely accepted that the ANT is a component of
the PTP assembly [12] and that the redox state of two of its
thiol groups plays a crucial role in the mechanism of PTP
opening [11]. Oxidation of these thiols by thiol reagents, re-
active oxygen or via a redox link with the oxidized state of
pyridine nucleotides (PN) facilitates PTP opening [13]. An
earlier report [11] provided evidence that both cyclophilin D
(CyP-D) binding and ADP displacement from distinct sites on
the ANT increased the a⁄nity of Ca2 binding to the protein
site(s) which trigger(s) pore opening. Both mechanisms appear
to be stimulated by oxidation of the thiol groups on the ANT
[11], a process that may also mediate the DTT-sensitive PTP
opening induced by both AA and FCCP in the present work.
Linolenic acid, which, together with AA, accounts for the
bulk of mitochondrial phospholipids (see [24]), has an e¡ect
similar to that produced by AA (not shown).
The data presented here demonstrate that NAD(P)H and
protein thiol oxidation associated with the stimulation of oxy-
gen consumption induced by mild uncoupling by either FCCP
or AA participate in the mechanism of PTP opening. This is
illustrated by the inhibition of pore opening by either rote-
none or NAD-linked substrates which signi¢cantly decrease
NAD(P)H oxidation in RLM oxidizing succinate. If
NAD(P) is re-reduced by rotenone or NAD(P)H-linked sub-
strates, opening of the PTP is also prevented. Therefore, a link
between the thiol redox state of the translocase and that of
NAD(P)H seems to underlie the mechanism of PTP opening
by both AA and FCCP. In this regard, a decrease in the
number of inner membrane protein sulfhydryl groups and
ANT conformation is reportedly associated with the oxidation
of PN in Ca2-loaded rat liver mitochondria [18]. PTP open-
ing occurred under these conditions. The inhibition of pore
opening by DTT (Fig. 1), a dithiol reductant, is consistent
with this mechanism. On the other hand, ADP and CsA,
although unable to prevent NAD(P)H and, probably, ANT
thiol oxidations, did inhibit PTP opening by a direct interac-
tion with the inhibitory site on the ANT or by removing
bound CyP-D, respectively. In both cases, the oxidation of
ANT thiols was overcome by the e¡ects of CsA and ADP
[11]. Based on the present results, we propose that the ability
of FA to open the PTP is, as in the case of FCCP, a conse-
quence of NAD(P)H oxidation that occurs through an in-
crease in the rate of respiration mediated by the protonophor-
ic action of these compounds. In both situations, a condition
of oxidative stress generated by the lack of reducing equiva-
lents from NAD(P)H to the antioxidant system glutathione
reductase/peroxidase favors PTP opening. This notion is
strongly supported by the experiment showing that removal
of H2O2 by exogenous catalase prevented the mitochondrial
permeability transition. It is assumed that AA-induced uncou-
pling was mediated by ANT and the aspartate/glutamate anti-
porter as proposed by Samartsev et al. [5], since liver mito-
chondria do not contain a su⁄cient amount of uncoupling
protein-2 [23]. This assumption was con¢rmed by the lack
of the inhibitory e¡ect of GDP on the ¢rst uncoupling phase
(not shown).
The present results should also be discussed in view of the
¢ndings of Korshunov et al. [24] and Cocco et al. [25]. The
¢rst group presented evidence that micromolar concentrations
of FA cause mild uncoupling and arrest ROS formation by
rat heart mitochondria respiring on succinate in Ca2-free
medium. The second group reported that AA and other FA
interactions with intact bovine heart mitochondria, while
causing uncoupling, also markedly inhibit uncoupled respira-
tion at the level of respiratory complexes I and III, with a
consequent stimulation of ROS production. Our results are
not contrary to these studies since our experiments were car-
ried out with Ca2-loaded rat liver mitochondria under exper-
imental conditions in which there was only a slight di¡erence
in the rate of AA- and FCCP-induced uncoupling (Fig. 3).
The accumulation of ROS is certainly a consequence of in-
creased production resulting from the membrane perturbation
caused by Ca2 binding to negative phospholipids on the in-
ternal face of the inner mitochondrial membrane [26]. As pre-
viously proposed [27], this Ca2 e¡ect is potentiated when
associated with the lack of reducing equivalents from
NAD(P)H to feed the mitochondrial antioxidant systems.
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